OpenVSafe by OpenVAERS
Search V-safe

PAP-11264-67679

1 vaccination 5 coded responses 14 check-ins 5 free-text entries 0 call cases
Sex
Female
Age at first dose
05-11
ZIP prefix
162 / PA
Registered
2021-12-14
Relationship
Child or adolescent in my care
Guardian
UZP-33859-26230
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-12-14
    Registered in v-safe
  2. 2021-12-14
    Dose 1 — Pfizer-BioNTech
  3. 2021-12-14
    Health check-in — day 0, dose 1, dependent
    Feeling: Good · None
    Adult check-in
  4. 2021-12-15
    Health check-in — days 1–6 daily, dose 1, dependent
    Feeling: Good · Site: Pain · None
    Adult check-in
  5. 2021-12-17
    Health check-in — days 1–6 daily, dose 1, dependent
    Feeling: Good · None
    Adult check-in
  6. 2021-12-18
    Health check-in — days 1–6 daily, dose 1, dependent
    Feeling: Good · None
    Adult check-in
  7. 2021-12-19
    Survey response — days 1–6 daily, dose 1, dependent
    MedDRA: Sinus congestion — Feeling: Fair · Headache
    Free text: Sinus congestion
    MedDRA releases: 2024-11 · check-in free text available
  8. 2021-12-20
    Survey response — days 1–6 daily, dose 1, dependent
    MedDRA: Nasal congestion — Feeling: Fair
    Free text: Nasal congestion
    MedDRA releases: 2024-11 · check-in free text available
  9. 2021-12-21
    Survey response — day 7, dose 1, dependent
    MedDRA: Nasal congestion — Feeling: Good
    Free text: Nasal congestion
    MedDRA releases: 2024-11 · check-in free text available
  10. 2021-12-28
    Health check-in — day 14, dose 1, dependent
    Feeling: Good
    Adult check-in
  11. 2022-01-04
    Survey response — day 21, dose 1, dependent
    MedDRA: Decreased appetite, Nausea, Vomiting — Feeling: Poor · Be unable to work or attend school
    Free text: Nasuea vomiting, decreased appetite
    MedDRA releases: 2024-11 · check-in free text available
  12. 2022-01-11
    Health check-in — day 28, dose 1, dependent
    Feeling: Good
    Adult check-in
  13. 2022-01-18
    Health check-in — day 35, dose 1, dependent
    Feeling: Good
    Adult check-in
  14. 2022-01-25
    Survey response — day 42, dose 1, dependent
    MedDRA: Conjunctivitis, Headache, Pyrexia, Respiratory tract congestion, SARS-CoV-2 test negative — Feeling: Fair · Be unable to work or attend school
    Free text: Fever headache congestion conjunctivitis. Negative covid test times 2
    MedDRA releases: 2024-11 · check-in free text available
  15. 2022-03-15
  16. 2022-06-14

Vaccinations

DoseDateManufacturerCo-administered
12021-12-14Pfizer-BioNTech No

Free text

Release 10 — days 1–6 daily, dose 1, dependent

2021-12-19

Systemic reaction (other): Sinus congestion

2021-12-20

Systemic reaction (other): Nasal congestion

Release 10 — day 7, dose 1, dependent

2021-12-21

Systemic reaction (other): Nasal congestion

Release 10 — day 21, dose 1, dependent

2022-01-04

Symptoms: Nasuea vomiting, decreased appetite

Release 11 — day 42, dose 1, dependent

2022-01-25

Symptoms: Fever headache congestion conjunctivitis. Negative covid test times 2

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDConjunctivitis · · ✓
SDDecreased appetite · · ✓
SDHeadache · · ✓
SDNausea · · ✓
SDPyrexia · · ✓
SDRespiratory tract congestion · · ✓
SDSARS-CoV-2 test negative · · ✓
SDVomiting · · ✓
SRONasal congestion · · ✓
SROSinus congestion · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release